The 340B Discount Drug Program, enacted by Congress in 1992, continues to be a target for criticism and has been challenged several times by its opponents. Its overall purpose is to allow healthcare organizations serving indigent and rural populations to receive medical care and medications at reduced cost.

In response to a request from the Rural and Agricultural Group of America, Visante CEO, Jim Jorgenson, submitted this Op-Ed to the Salt Lake Tribute.

Share this on Twitter: